Impact of Ocular Surface Disease Treatment in Patients with Glaucoma.

Ana Luiza Mylla BosoErica GasperiLeticia FernandesVital Paulino CostaMonica Alves

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

The prevalence of OSD signs and symptoms was high in glaucoma patients under medical treatment. Short-term OSD treatment may improve ocular surface disease and IOP control, with no need to discontinue glaucoma medications.

Keyphrases

end stage renal disease
healthcare
chronic kidney disease
newly diagnosed
ejection fraction
optic nerve
combination therapy
prognostic factors